BANK OF AMERICA CORP /DE/ - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$11,891
+1189000.0%
9,218
+921700.0%
0.00%
Q2 2023$1
-100.0%
1
-100.0%
0.00%
Q1 2023$14,955
-70.5%
21,183
-68.6%
0.00%
Q4 2022$50,648
+80.9%
67,530
+106.4%
0.00%
Q3 2022$28,000
-62.2%
32,725
-51.1%
0.00%
Q2 2022$74,000
-66.8%
66,878
-66.5%
0.00%
Q1 2022$223,000
+95.6%
199,649
+180.1%
0.00%
Q4 2021$114,000
+15.2%
71,282
+74.5%
0.00%
Q3 2021$99,000
-42.8%
40,840
-25.0%
0.00%
Q2 2021$173,000
+2783.3%
54,433
+3189.0%
0.00%
Q1 2021$6,0000.0%1,6550.0%0.00%
Q4 2020$6,000
+20.0%
1,6550.0%0.00%
Q3 2020$5,0000.0%1,6550.0%0.00%
Q2 2020$5,000
+400.0%
1,6550.0%0.00%
Q1 2020$1,000
-83.3%
1,6550.0%0.00%
Q4 2019$6,000
-83.3%
1,655
-86.3%
0.00%
Q3 2019$36,000
+16.1%
12,1040.0%0.00%
Q2 2019$31,00012,1040.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q2 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,048,757$6,904,0002.75%
Asymmetry Capital Management, L.P. 1,063,264$3,583,0001.85%
Endurant Capital Management LP 1,339,835$4,515,0001.18%
Altium Capital Management LP 1,250,000$4,213,0001.17%
Affinity Asset Advisors, LLC 900,000$3,033,0001.03%
DAFNA Capital Management LLC 1,249,648$4,211,0001.00%
Boxer Capital, LLC 6,226,673$20,984,0000.71%
Delphi Management Partners VIII, L.L.C. 256,734$865,0000.60%
Rubric Capital Management LP 2,914,861$9,823,0000.57%
Orbimed Advisors 17,264,763$58,183,0000.54%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders